Compare Liquidia Corporation Common Stock (LQDA) vs Nano Dimension Ltd - ADR (NNDM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Nano Dimension Ltd - ADR — how do they compare? Liquidia Corporation Common Stock trades at $33.69 (market cap $2.40B), while Nano Dimension Ltd - ADR trades at $1.39 (market cap $306.41M). The key difference: Liquidia Corporation Common Stock is far larger — about 7.8× Nano Dimension Ltd - ADR's market cap, and Liquidia Corporation Common Stock is more actively traded (2,857,547 versus 1,735,346). Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Nano Dimension Ltd - ADR for 43 Days on average.
| LQDA | NNDM | |
|---|---|---|
Market Cap | $2.40B | $306.41M |
Volume | 2,857,547 | 1,735,346 |
Sector | Health | Technology |
52-Week High | $91.03 | $2.14 |
52-Week Low | $22.02 | $1.21 |
Typical Hold Time | 0 Days | 43 Days |
Enterprise Value | $2.30B | -$98.44M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Nano Dimension (NNDM) trades at $1.41, down 6.62% with a bearish technical signal. The company shows revenue growth to $102.44M in 2025 but deepens net losses to -$293.30M, resulting in a negative net margin of -286.32%. Recent strategic moves include appointing a new board member and cost-saving initiatives targeting $25M in annual cash burn reduction. The stock faces significant selling pressure with 18 sell signals versus 7 buy signals in technical indicators.
The outlook remains challenging with persistent losses despite revenue growth. Investment opportunity exists in the company's cash position of $757.96M and low EV/EBITDA of 0.19, but risks include negative cash flow, leadership transitions, and shareholder activism. The stock trades near support levels with institutional sentiment cautious amid ongoing restructuring efforts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Nano Dimension Ltd - ADR
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →
